Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

October 25, 2022

https://www.globenewswire.com/news-release/2022/10/25/2541107/0/en/Neuronetics-Announces-Updated-TMS-Coverage-Policies-That-Will-Expand-Patient-Access-to-NeuroStar-TMS-Therapy-for-Mental-Health.html

MALVERN, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced healthcare policy updates that increase patient access to NeuroStar Advanced Therapy for Mental Health transcranial magnetic stimulation (TMS). The published and proposed updates will affect nearly 8 million covered lives.

Read more at globenewswire.com

Related news for (STIM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.